John W Kozarich insider trades: Ligand Pharmaceuticals (LGND) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | LGND | ↓ Sell10b5-1 | 2,501 | $225.14 | $563K | Direct | May 14, 2026 (1d) |
| Apr 1, 2026 | LGND | ↓ Sell10b5-1 | 467 | $202.23 | $94K | Direct | Apr 2, 2026 (1d) |
| Mar 2, 2026 | LGND | ↓ Sell10b5-1 | 467 | $200.50 | $94K | Direct | Mar 4, 2026 (2d) |
| Feb 2, 2026 | LGND | ↓ Sell10b5-1 | 467 | $195.91 | $91K | Direct | Feb 4, 2026 (2d) |
| Jan 2, 2026 | LGND | ↓ Sell10b5-1 | 467 | $189.58 | $89K | Direct | Jan 6, 2026 (4d) |
| Dec 1, 2025 | LGND | ↓ Sell10b5-1 | 467 | $195.84 | $91K | Direct | Dec 3, 2025 (2d) |
| Nov 3, 2025 | LGND | ↓ Sell10b5-1 | 467 | $191.05 | $89K | Direct | Nov 5, 2025 (2d) |
| Oct 1, 2025 | LGND | ↓ Sell10b5-1 | 467 | $179.44 | $84K | Direct | Oct 3, 2025 (2d) |
| Sep 2, 2025 | LGND | ↓ Sell10b5-1 | 467 | $162.26 | $76K | Direct | Sep 4, 2025 (2d) |
| Aug 1, 2025 | LGND | ↓ Sell10b5-1 | 467 | $131.88 | $62K | Direct | Aug 5, 2025 (4d) |
| Jul 10, 2025 | LGND | ↓ Sell10b5-1 | 934 | $125.00 | $117K | Direct | Jul 11, 2025 (1d) |
| May 16, 2023 | LGND | ↓ Sell | 4,444 | $77.20 | $343K | Direct | May 18, 2023 (2d) |
| May 8, 2023 | LGND | ↓ Sell | 6,408 | $76.56 | $491K | Direct | May 10, 2023 (2d) |
| Feb 28, 2022 | LGND | ↓ Sell | 908 | $102.62 | $93K | Direct | Mar 1, 2022 (1d) |
| Aug 23, 2019 | NTEC | ↑ Buy | 100,000 | $0.46 | $46K | Direct | Aug 27, 2019 (4d) |
| May 14, 2019 | LGND | ↓ Sell | 2,500 | $112.92 | $282K | Direct | May 14, 2019 (0d) |
| Oct 1, 2018 | LGND | ↓ Sell10b5-1 | 2,500 | $275.04 | $688K | Direct | Oct 2, 2018 (1d) |
| Jul 2, 2018 | LGND | ↓ Sell10b5-1 | 2,500 | $207.48 | $519K | Direct | Jul 3, 2018 (1d) |
| Apr 2, 2018 | LGND | ↓ Sell10b5-1 | 2,500 | $160.43 | $401K | Direct | Apr 3, 2018 (1d) |
| Jan 10, 2018 | LGND | ↓ Sell10b5-1 | 2,500 | $145.00 | $363K | Direct | Jan 11, 2018 (1d) |
| Nov 16, 2017 | LGND | ↓ Sell | 5,000 | $141.71 | $709K | Direct | Nov 17, 2017 (1d) |
| Sep 7, 2016 | LGND | ↓ Sell10b5-1 | 1,000 | $115.00 | $115K | Direct | Sep 9, 2016 (2d) |
| Sep 1, 2016 | LGND | ↓ Sell10b5-1 | 1,666 | $105.40 | $176K | Direct | Sep 6, 2016 (5d) |
| Aug 1, 2016 | LGND | ↓ Sell10b5-1 | 1,000 | $137.57 | $138K | Direct | Aug 2, 2016 (1d) |
| Jul 1, 2016 | LGND | ↓ Sell10b5-1 | 1,000 | $121.40 | $121K | Direct | Jul 5, 2016 (4d) |
| Jun 1, 2016 | LGND | ↓ Sell10b5-1 | 1,000 | $117.42 | $117K | Direct | Jun 3, 2016 (2d) |
| May 2, 2016 | LGND | ↓ Sell10b5-1 | 1,000 | $121.57 | $122K | Direct | May 3, 2016 (1d) |
| Apr 6, 2016 | LGND | ↓ Sell10b5-1 | 5,000 | $115.00 | $575K | Direct | Apr 7, 2016 (1d) |
| Jan 20, 2016 | LGND | ↓ Sell10b5-1 | 1,666 | $94.94 | $158K | Direct | Jan 22, 2016 (2d) |
| Dec 22, 2014 | QLTI | ↑ Buy | 10,000 | $3.59 | $36K | Direct | Dec 23, 2014 (1d) |
| Oct 15, 2014 | LGND | ↑ Buy | 2,000 | $45.68 | $91K | Direct | Oct 15, 2014 (0d) |
| May 13, 2013 | QLTI | ↑ Buy | 10,000 | $7.97 | $80K | Direct | May 14, 2013 (1d) |
| Nov 11, 2011 | LGNDD | ↑ Buy | 1,000 | $11.79 | $12K | Direct | Nov 14, 2011 (3d) |
| Feb 17, 2011 | LGND | ↑ Buy | 1,000 | $9.90 | $10K | Direct | Feb 17, 2011 (0d) |
| Nov 11, 2010 | LGND | ↑ Buy | 10,000 | $1.60 | $16K | Direct | Nov 12, 2010 (1d) |
| May 10, 2010 | LGND | ↑ Buy | 10,000 | $1.68 | $17K | Direct | May 11, 2010 (1d) |
| Mar 5, 2008 | LGND | ↑ Buy | 3,000 | $3.66 | $11K | Direct | Mar 6, 2008 (1d) |
| Nov 20, 2007 | LGND | ↑ Buy | 2,000 | $4.28 | $9K | Direct | Nov 23, 2007 (3d) |
| Aug 29, 2007 | LGND | ↑ Buy | 1,000 | $6.14 | $6K | Direct | Aug 29, 2007 (0d) |
| Aug 13, 2007 | LGND | ↑ Buy | 2,000 | $6.01 | $12K | Direct | Aug 14, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LGND insiders
Open-market trades in the last 12 months
About John W Kozarich's insider trades
John W Kozarich is a director at Ligand Pharmaceuticals (LGND). Since Aug 13, 2007, John has reported 12 open-market purchases worth $345K and 28 sales worth $6.9M on SEC Form 4. In the last 12 months: 6 sales ($1.0M).
23 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (38 filings), option exercises (16 filings), gifts (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LGND insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.